Corrected: BRIEF-Evotec 9M Adj. EBITDA Loss at EUR -6 Million
06/11/2024 06:10
Nov 6 (Reuters) - 9M revenue EUR 575.7 million * 9M adjusted EBITDA EUR -6 Million * Outlook FY adjusted EBITDA EUR 15-35 million * Outlook FY revenue EUR 790-820 million
Recent news on Evotec SE
See all newsEvotec up 7% in early trade after 9-month revenue, earnings beat
Brief: Evotec Says Preliminary Nine-Month 2026 Results Above Market Expectations
Brief: Evotec Initiates Phase 1 Trial For Jst-018 Antibodies Targeting Orthopoxviruses
Brief: EVOTEC Q2 Group Revenues €143.50 Mln
Brief: Evotec And Odyssey Therapeutics Enter AI-Enabled R&D Collaboration In Autoimmune And Inflammatory Diseases